TRT: When to Start? Balancing Symptoms, Age, and Lab Numbers

Men with total testosterone below 300 ng/dL have a 2.4 times higher cardiovascular mortality risk compared to those with levels above 900 ng/dL, according to a prospective study published in the Journal of Clinical Endocrinology & Metabolism (JCEM, 2018) involving over 8,000 men. This stark statistic underscores testosterone’s critical role beyond just sexual health, impacting overall longevity and quality of life. Yet, deciding when to initiate Testosterone Replacement Therapy (TRT) remains a complex interplay between subjective symptoms and objective lab numbers.

Last Updated: OCTOBER 2023

The Shifting Landscape of “Normal” Testosterone

For decades, the benchmark for diagnosing low testosterone, often termed hypogonadism, has hinged on arbitrary reference ranges. Many clinical guidelines still reference a lower total testosterone threshold of approximately 300 ng/dL. However, this number is frequently cited as originating from studies in the 1970s that included a significant proportion of sick and elderly men, effectively lowering the population average and skewing the definition of “normal.” This historical context has unfortunately led to a system that may gatekeep effective treatment from men experiencing significant symptoms despite technically falling within a broad “normal” range.

The reality is that testosterone levels naturally decline with age, but this decline does not universally dictate a man’s symptomatic experience. A 35-year-old with a total testosterone of 350 ng/dL might experience profound symptoms of hypogonadism, while a 60-year-old with the same level might feel perfectly fine. This highlights the crucial distinction between population-level averages and individual physiological needs.

When Symptoms Speak Louder Than Numbers

The decision to start TRT should fundamentally be patient-centric. While lab values provide an objective snapshot, a man’s subjective experience of his health and well-being often offers a more complete picture of his hormonal status. For many men, debilitating symptoms manifest long before their total testosterone dips below conventional “normal” thresholds.

Common symptoms of low testosterone include:

• Sexual Dysfunction: Decreased libido, erectile dysfunction, reduced spontaneous erections.
• Physical Changes: Decreased muscle mass and strength, increased body fat (especially abdominal), reduced bone density, fatigue, hair loss.
• Mental & Emotional Changes: Depression, irritability, poor concentration, reduced motivation, memory impairment, brain fog.
• Sleep Disturbances: Insomnia, difficulty falling or staying asleep.

These symptoms, particularly when they significantly impair quality of life, are often the primary drivers for men seeking evaluation. Ignoring severe symptoms because lab values are “technically normal” neglects the patient’s lived experience. The Endocrine Society’s Clinical Practice Guideline for Testosterone Therapy in Men (2018) states, “The diagnosis of hypogonadism requires both consistent symptoms and unequivocally low serum testosterone concentrations.” However, what constitutes “unequivocally low” is precisely where the interpretation differs. Many progressive clinicians advocate for treating symptoms in conjunction with labs, not solely by strict adherence to an outdated numerical cutoff.

The Indispensable Role of Lab Testing

While symptoms are paramount, comprehensive lab testing is non-negotiable for an accurate diagnosis and safe management of TRT. Before initiating therapy, a baseline panel helps rule out other conditions and establishes starting points for monitoring.

Key lab markers for evaluation include:

• Total Testosterone: The primary diagnostic marker, measured usually in the morning (between 7:00 AM and 10:00 AM) due to diurnal variation. Multiple low readings are often required.
• Free Testosterone: The biologically active portion of testosterone, unbound to proteins. Often a more accurate indicator of androgenic activity, especially if SHBG is abnormal.
• Sex Hormone Binding Globulin (SHBG): A protein that binds testosterone, impacting free testosterone levels. High SHBG can lead to low free T even with “normal” total T.
• Luteinizing Hormone (LH) & Follicle-Stimulating Hormone (FSH): Pituitary hormones that stimulate testosterone production. High LH/FSH with low T indicates primary hypogonadism (testicular failure). Low LH/FSH with low T indicates secondary hypogonadism (pituitary/hypothalamic issue).
• Estradiol (E2): The primary estrogen in men. Important for bone health, but excessively high levels can lead to gynecomastia, water retention, and mood changes.
• Prolactin: High prolactin can suppress testosterone and mimic symptoms of low T.
• Complete Blood Count (CBC): To check for polycythemia (elevated red blood cell count), a potential side effect of TRT.
• Prostate Specific Antigen (PSA): Baseline PSA is crucial before TRT, especially in older men, to screen for prostate issues.

Optimal vs. Reference Ranges

Understanding the difference between population-based reference ranges and optimal therapeutic ranges is critical for TRT success.

Age-Specific Considerations for Starting TRT

The decision to start TRT is not one-size-fits-all and should be tailored to a man’s age, life goals, and overall health status.

Younger Men (20s-30s)

In younger men, low testosterone is less common and often points to a secondary cause, such as pituitary dysfunction, substance abuse, chronic stress, obesity, or specific medical conditions. Fertility is a major concern, as exogenous testosterone therapy can suppress natural sperm production. For these men, alternatives like enclomiphene citrate (e.g., 12.5–25mg daily or every other day) can stimulate the testes to produce more testosterone while preserving fertility. If TRT is necessary, concurrent use of Human Chorionic Gonadotropin (HCG) (e.g., 500–1000 IU 2-3 times per week) is often recommended to maintain testicular function and size, and preserve fertility potential. A thorough investigation into the root cause of hypogonadism is paramount.

Middle-Aged Men (40s-50s)

This demographic often experiences a more significant decline in testosterone, coinciding with changes in lifestyle, increasing body fat, and potential onset of metabolic syndrome. Symptoms become more pronounced and persistent. For these men, TRT with testosterone cypionate or testosterone enanthate (e.g., 100–200mg per week, typically split into two injections) is a common and effective approach. The goal is symptom resolution, improved energy, better body composition, and enhanced libido. Fertility is less often a primary concern than in younger men, but HCG can still be considered to prevent testicular atrophy.

Older Men (60s+)

As men age, comorbidities become more prevalent, and the risk-benefit profile of TRT requires careful consideration. While TRT can improve energy, muscle mass, and bone density, potential risks like polycythemia and prostate concerns need close monitoring. A starting dose might be slightly lower, and adjustments made slowly. Regular PSA, CBC, and cardiovascular health assessments are crucial. The goal is to improve quality of life and functional capacity, maintaining a physiological level of testosterone, typically in the mid-to-high normal range (e.g., 700-1000 ng/dL total testosterone).

Initiating Therapy: Protocols and Monitoring

Once the decision is made to start TRT, most men begin with testosterone cypionate or testosterone enanthate injections. A typical starting protocol involves 100–200mg injected intramuscularly or subcutaneously per week, often split into two equal